Sample Header with Navigation Dropdowns
Sample Header with Navigation Dropdowns
Solutions Technology About
Profile Settings Logout
Solutions
Tele-Health Clinics Pharmacy Services Product & Cultivation
Technology
ScriptIT
Brands
Chemist Greenhouse 5Leaf Chronic Doctors CuratD Health
About

Biolife Group Acquires 20% Stake in AHA Corporate Pty Ltd, Enhancing Vertically Integrated Healthcare Solutions                                                                                                         

Herston, QLD


Biolife Group has officially acquired a 20% stake in AHA Corporate Pty Ltd, marking a significant milestone in the healthcare industry. This strategic investment completes the creation of a unique, vertically integrated business model that aims to revolutionise support services and profit margins for healthcare providers across Australia. 

The collaboration between Biolife Group and AHA Corporate Pty Ltd is poised to enhance the delivery of healthcare services by offering an integrated suite of products and systems designed to incorporate medicinal cannabis into traditional PBS (Pharmaceutical Benefits Scheme) pharmacy settings. This partnership brings together expertise in healthcare, pharmaceuticals, cutting-edge medicinal cannabis solutions and cultivation to provide comprehensive support to healthcare providers. 

Key Highlights of the Acquisition: 

• Strategic Investment: Biolife Group’s acquisition of a 20% stake in AHA Corporate Pty Ltd solidifies its position as a leader in the healthcare sector, particularly in the growing medicinal cannabis industry. 

• Vertically Integrated Business Model: The partnership creates a fully integrated business that spans healthcare support services, product supply, and advanced systems for medicinal cannabis integration into conventional pharmacy practices.

• Enhanced Support for Healthcare Providers: AHA Corporate Pty Ltd will leverage this investment to expand its service offerings, providing healthcare providers with the tools and support needed to incorporate medicinal cannabis seamlessly into their practices and pharmacies. 

QOUTES: “This acquisition is a game-changer for both Biolife Group and AHA Corporate Pty Ltd. By combining our strengths, we are uniquely positioned to provide healthcare providers with the resources they need to navigate the evolving landscape of medicinal cannabis. Our vertically integrated approach ensures that we can deliver high-quality products and services efficiently and effectively,” said Patrick Mauder, COO of Biolife Group. 

“We are thrilled to welcome Biolife Group as a strategic partner. Their investment underscores the potential of our integrated business model and our commitment to supporting healthcare providers across Australia. Together, we are setting a new standard for the incorporation of medicinal cannabis into traditional pharmacy practices,” said Brendon Rose, Managing Director of AHA Corporate Pty Ltd. 

About Biolife Group

BioLife Groups vision is to become the globally recognised leader in the ‘Farm-to-Patient’ cannabis industry, bridging the gap between natural cultivation and therapeutic innovation.  

The company capitalises on its distinct position as both a pioneering research entity and a commercial grower in the cannabis sector with cultivation facilities in Byron Bay Australia, Bangkok and Chiang Rai Thailand. The operations spearheaded by an elite team, supported by university partnerships and industry veterans. 

About AHA Corporate Pty Ltd

AHA Corporate Pty Ltd and it’s wholly owned subsidiaries, Alliance Healthcare Australia, CuratD Health, Chronic Doctors, ScriptIT, Chemist Greenhouse and 5LEAF, are providers of comprehensive support services for healthcare providers, offering access to discounts, rebates, technology systems, business analytics, and operational support. The company specialises in integrating medicinal cannabis into traditional PBS pharmacy settings, enhancing the capabilities of healthcare providers nationwide. 

Media Contact:  

Rachel Swiatkiewicz 

CCO 
Rachel@alliancehealthcare.com.au 

NEWS

Biolife Group Secures 20% Stake in AHA Corporate, Strengthening Cannabis Healthcare Integration Allicance

August 23, 2024

Biolife Group Acquires 20% Stake in AHA Corporate Pty Ltd, Enhancing Vertically Integrated Healthcare Solutions                                                                                                         

Herston, QLD


Biolife Group has officially acquired a 20% stake in AHA Corporate Pty Ltd, marking a significant milestone in the healthcare industry. This strategic investment completes the creation of a unique, vertically integrated business model that aims to revolutionise support services and profit margins for healthcare providers across Australia. 

The collaboration between Biolife Group and AHA Corporate Pty Ltd is poised to enhance the delivery of healthcare services by offering an integrated suite of products and systems designed to incorporate medicinal cannabis into traditional PBS (Pharmaceutical Benefits Scheme) pharmacy settings. This partnership brings together expertise in healthcare, pharmaceuticals, cutting-edge medicinal cannabis solutions and cultivation to provide comprehensive support to healthcare providers. 

Key Highlights of the Acquisition: 

• Strategic Investment: Biolife Group’s acquisition of a 20% stake in AHA Corporate Pty Ltd solidifies its position as a leader in the healthcare sector, particularly in the growing medicinal cannabis industry. 

• Vertically Integrated Business Model: The partnership creates a fully integrated business that spans healthcare support services, product supply, and advanced systems for medicinal cannabis integration into conventional pharmacy practices.

• Enhanced Support for Healthcare Providers: AHA Corporate Pty Ltd will leverage this investment to expand its service offerings, providing healthcare providers with the tools and support needed to incorporate medicinal cannabis seamlessly into their practices and pharmacies. 

QOUTES: “This acquisition is a game-changer for both Biolife Group and AHA Corporate Pty Ltd. By combining our strengths, we are uniquely positioned to provide healthcare providers with the resources they need to navigate the evolving landscape of medicinal cannabis. Our vertically integrated approach ensures that we can deliver high-quality products and services efficiently and effectively,” said Patrick Mauder, COO of Biolife Group. 

“We are thrilled to welcome Biolife Group as a strategic partner. Their investment underscores the potential of our integrated business model and our commitment to supporting healthcare providers across Australia. Together, we are setting a new standard for the incorporation of medicinal cannabis into traditional pharmacy practices,” said Brendon Rose, Managing Director of AHA Corporate Pty Ltd. 

About Biolife Group

BioLife Groups vision is to become the globally recognised leader in the ‘Farm-to-Patient’ cannabis industry, bridging the gap between natural cultivation and therapeutic innovation.  

The company capitalises on its distinct position as both a pioneering research entity and a commercial grower in the cannabis sector with cultivation facilities in Byron Bay Australia, Bangkok and Chiang Rai Thailand. The operations spearheaded by an elite team, supported by university partnerships and industry veterans. 

About AHA Corporate Pty Ltd

AHA Corporate Pty Ltd and it’s wholly owned subsidiaries, Alliance Healthcare Australia, CuratD Health, Chronic Doctors, ScriptIT, Chemist Greenhouse and 5LEAF, are providers of comprehensive support services for healthcare providers, offering access to discounts, rebates, technology systems, business analytics, and operational support. The company specialises in integrating medicinal cannabis into traditional PBS pharmacy settings, enhancing the capabilities of healthcare providers nationwide. 

Media Contact:  

Rachel Swiatkiewicz 

CCO 
Rachel@alliancehealthcare.com.au 

Stay in the Know

Subscribe to our newsletter for the latest resources straight to your inbox!

Related Content

Alliance Healthcare Australia Appoints The Entourage Effect as Exclusive Distribution Partner for 5LEAF & first-line supplier to the Alliance Healthcare Australia Group of pharmacy members.

Related Content

Alliance Healthcare Australia Launches Premium Medical Cannabis Products: 5 LEAF NORTH and 5LEAF SOUTH

Innovators in Healthcare

GENERAL INQUIRY

MEMBER SUPPORT

QUICK LINKS

Privacy Policy Modal
Footer Example

Privacy Policy.

At Alliance Healthcare Australia, we are committed to protecting your privacy and ensuring that your personal information is handled in a safe and responsible manner. This policy outlines how we collect, use, hold, and disclose your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles (APPs).

  1. About Us

Alliance Healthcare Australia ABN 14 668 671 083 provides services including:

  • Access to discounts and rebates related to the purchase of pharmaceutical and other products.
  • Marketing support, including for clinics run by pharmacies under the AHA Corporate brands.
  • Access to purchasing technology systems.
  • Business analytics and operational support to group members.
  1. Collection of Personal Information

We collect personal information necessary to provide our services effectively. This may include:

  • Contact Details: Such as your name, address, phone number, and email address.
  • Health Information: Including details of your medical history and medications, where relevant.
  • Financial Information: Such as credit card details and bank account information for payment purposes.
  • Business Information: Information related to your use of our purchasing technology systems and other operational support services.
  1. Use of Personal Information

Your personal information is used to:

  • Provide and manage the services we offer, including processing discounts, rebates, and providing business analytics.
  • Communicate with you regarding our services, updates, and other relevant information.
  • Comply with legal obligations, such as reporting requirements under applicable laws.
  • Improve our services by analysing data and customer feedback.
  1. Holding of Personal Information

We take reasonable steps to protect your personal information from misuse, interference, loss, unauthorized access, modification, or disclosure. Information is stored securely and retained only for as long as necessary to fulfill the purposes for which it was collected, or as required by law.

  1. Disclosure of Personal Information

We may disclose your personal information to third parties, including:

  • Service Providers: Who assist us in providing our services, such as IT and marketing support providers.
  • Business Partners: Involved in the delivery of services, such as pharmacies and healthcare professionals.
  • Legal Authorities: When required by law or to protect our legal rights.
  • With Your Consent: Where you have expressly agreed to the disclosure.
  1. Access to and Correction of Personal Information

You have the right to access the personal information we hold about you and request corrections if needed. To do so, please contact us using the details provided below. We will respond to your request within a reasonable timeframe.

  1. Complaints and Contact Information

If you have any complaints or concerns about how we handle your personal information, or if you wish to access or correct your information, please contact us at:

Alliance Healthcare Australia
7 Butterfield Street, Herston QLD 4006
info@alliancehealthcare.com.au

We will investigate your complaint and respond promptly. If you are not satisfied with our response, you may escalate your complaint to the Office of the Australian Information Commissioner (OAIC).

  1. Changes to this Privacy Policy

We may update this Privacy Policy periodically to reflect changes in our practices or legal obligations. Any updates will be posted on our website, and we encourage you to review this policy regularly.

This Privacy Policy was last updated on 16th August 2024